As pharmaceutical companies attempt to interact with consumers and patients on social media networks they host, they are wary of overstepping undefined regulatory boundaries. One issue that requires clarification concerns accountability for user-generated content posted on these pharma owned and controlled social networks such as comments submitted to Facebook pages and YouTube channels.
This article presents a summary of results from a recent survey of readers and other experts regarding pharma social media moderation best practices.
Read this article now. It's FREE...
- What's Your Social Media Implementation Plan?
- Unmoderated Discussions
- Does Pre-Screening Inhibit Discussion?
- Post-Moderation Best Practices
- Who Should Moderate?
Download PDF file